αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation

被引:0
|
作者
L Kordelas
U Buttkereit
M Lindemann
M Koldehoff
V Klisanin
P A Horn
K Fleischhauer
D W Beelen
机构
[1] University Hospital Essen,Department of Bone Marrow Transplantation
[2] Institute for Transfusion Medicine,undefined
[3] University Hospital Essen,undefined
[4] Institute for Experimental Cellular Therapy,undefined
[5] University Hospital Essen,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1668 / 1670
页数:2
相关论文
共 50 条
  • [21] Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
    Ko K. Maung
    Benny J. Chen
    Ian Barak
    Zhiguo Li
    David A. Rizzieri
    Cristina Gasparetto
    Keith M. Sullivan
    Gwynn D. Long
    Ashley M. Engemann
    Barbara Waters-Pick
    Krista Rowe Nichols
    Richard Lopez
    Yubin Kang
    Stefanie Sarantopoulos
    Anthony D. Sung
    Nelson J. Chao
    Mitchell E. Horwitz
    Bone Marrow Transplantation, 2021, 56 : 137 - 143
  • [22] Phase I, Dose Escalation Study of Naive T-Cell Depleted Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation
    Maung, Ko Ko
    Chen, Benny J.
    Rizzieri, David A.
    Gasparetto, Cristina
    Sullivan, Keith
    Long, Gwynn D.
    Engemann, Ashley Morris
    Waters-Pick, Barbara
    Nichols, Krista Rowe
    Lopez, Richard
    Kang, Yubin
    Sarantopoulos, Stefanie
    Sung, Anthony D.
    Chao, Nelson J.
    Horwitz, Mitchell E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [23] Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
    Maung, Ko K.
    Chen, Benny J.
    Barak, Ian
    Li, Zhiguo
    Rizzieri, David A.
    Gasparetto, Cristina
    Sullivan, Keith M.
    Long, Gwynn D.
    Engemann, Ashley M.
    Waters-Pick, Barbara
    Nichols, Krista Rowe
    Lopez, Richard
    Kang, Yubin
    Sarantopoulos, Stefanie
    Sung, Anthony D.
    Chao, Nelson J.
    Horwitz, Mitchell E.
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 137 - 143
  • [24] Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
    van der Zouwen, Boris
    Koster, E. A. S.
    von dem Borne, P. A.
    Oosten, L. E. M.
    Roza-Scholten, M. W. I.
    Snijders, T. J. F.
    van Lammeren, D.
    van Balen, P.
    Marijt, W. A. F.
    Veelken, H.
    Falkenburg, J. H. F.
    de Wreede, L. C.
    Halkes, C. J. M.
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1203 - 1213
  • [25] Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
    Boris van der Zouwen
    E. A. S. Koster
    P. A. von dem Borne
    L. E. M. Oosten
    M. W. I. Roza-Scholten
    T. J. F. Snijders
    D. van Lammeren
    P. van Balen
    W. A. F. Marijt
    H. Veelken
    J. H. F. Falkenburg
    L. C. de Wreede
    C. J. M. Halkes
    Annals of Hematology, 2023, 102 : 1203 - 1213
  • [26] Update on CD8-depleted donor-lymphocyte infusions after T-cell depleted allogeneic hemopoietic stem cell transplantation
    Wagner, E-M.
    Wehler, D.
    Kolbe, K.
    Theobald, M.
    Herr, W.
    Meyer, R. G.
    ONKOLOGIE, 2011, 34 : 300 - 301
  • [27] Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?
    Robin, Marie
    LANCET HAEMATOLOGY, 2024, 11 (09): : e642 - e643
  • [28] Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation
    Gilman, Andrew L.
    Leung, Wing
    Cowan, Morton J.
    Cannon, Mark
    Epstein, Stacy
    Barnhart, Carrie
    Shah, Krishna
    Hyland, Michelle
    Fukes, Tracy
    Ivanova, Anastasia
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (02) : 169 - 178
  • [29] Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia
    Demiroglu, Haluk
    Aladag, Elifcan
    Chao, Nelson J.
    Buyukasik, Yahya
    Goker, Hakan
    BLOOD, 2019, 134
  • [30] Donor lymphocyte infusion (DLI) for mixed chimerism 6 months after T cell depleted allogeneic stem cell transplantation (TCD alloSCT) may prevent relapse.
    Marijt, Erik W. A.
    Borne, Peter A. Von Dem
    Barge, Renee M. Y.
    Deutz, Piette P.
    Beaumont, M. Floor
    Starrenburg, C. W. J. Ingrid
    Fibbe, Willem E.
    Willemze, Roelof
    Falkenburg, J. H. Frederik
    BLOOD, 2006, 108 (11) : 1050A - 1050A